ArticleNutrition & metabolism2026
Anemia status transitions, cumulative hemoglobin exposure, and component-specific associations with sarcopenia.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSarcopenia and anemia co-occur frequently among middle-aged and older adults, yet the relationship between anemia status transitions and sarcopenia remains poorly characterized.
methodsDrawing on data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted an analysis of 2,507 participants aged 45 years and older who were free of sarcopenia at baseline. Anemia was defined according to World Health Organization criteria as hemoglobin levels < 13 g/dL for men and < 12 g/dL for women. Anemia status transitions between 2011 and 2015 were classified as persistent non-anemia, incident anemia, resolved anemia, and persistent anemia. Sarcopenia and its components were ascertained in 2015 according to the Asian Working Group for Sarcopenia 2019 criteria. Multivariable logistic regression, restricted cubic spline analysis, subgroup analyses, and multiple sensitivity analyses were performed.
resultsPersistent anemia was significantly associated with higher odds of sarcopenia compared with persistent non-anemia (OR = 1.85, 95% CI: 1.06-3.24). Associations were most evident for low muscle mass, particularly among participants with resolved anemia (OR = 1.57, 95% CI: 1.00-2.47) and persistent anemia (OR = 1.73, 95% CI: 1.09-2.75). Cumulative hemoglobin exposure demonstrated a significant inverse dose-response relationship with both low muscle mass and sarcopenia, with each standard deviation increment associated with 17% and 21% lower odds, respectively.
conclusionsAnemia status transitions and cumulative hemoglobin exposure were associated with sarcopenia-related outcomes among middle-aged and older Chinese adults, with associations concentrated in the muscle mass domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.